CN107213291A - A kind of Chinese medicine composition - Google Patents
A kind of Chinese medicine composition Download PDFInfo
- Publication number
- CN107213291A CN107213291A CN201710420818.2A CN201710420818A CN107213291A CN 107213291 A CN107213291 A CN 107213291A CN 201710420818 A CN201710420818 A CN 201710420818A CN 107213291 A CN107213291 A CN 107213291A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- prepared
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
It is used to treat insomnia, nervous headache, hypoimmunity Chinese medicine composition the invention discloses one kind, is mainly made up of the bulk drug of following parts by weight：9 parts of cow-bezoar 7 part, 20 parts of calamus 15 part, 2 parts of the rhizome of Chinese monkshood 1 part, 5 parts of Moschus 3 part, 14 parts of styrax 10 part, 15 parts of asafoetide 12 part, 2 parts of sulphur 1 part, 12 parts of eclipta 9 part, 25 parts of myrobalan 18 part.Prescription of the present invention is simple, and active ingredient is clear and definite；Onset time is fast；Curative effect time is short；Taking dose is small；Toxic side effect is small；And pharmacological dependence will not be produced.
Description
Technical field
The invention belongs to Chinese medicine compound prescription technical field, and in particular to a kind of Chinese medicine composition.
Background technology
With the pressure in terms of the quickening of people's rhythm of life, and society, family, more and more people suffer from now
There are the symptoms such as insomnia, nervous headache, immunity degradation, the pain on huge body ＆ mind is brought to patient.
Insomnia is that one kind as caused by many factors such as Physical factors, psychological factor, environmental factor, biological agent factor is faced
Bed common disease, its be mainly presented with difficulty falling asleep, sleep it is not deep, easily wake up with a start, feel dreaminess, early awakening, it is awake after be difficult to fall asleep, wake up
After feel tired or lack clear-headed sense, daytime is drowsy.Modern Western medicine based on Benzodiazepines, is somebody's turn to do to the drug therapy of insomnia
Class medicine can shorten Sleep latency, reduce the awakening number of times in nighttime sleep, and NREM sleep (NREM) the I phases shorten,
The II phases extend, and III, IV phase substantially shorten, and rapid-eye-movement sleep (REM) time shortens, but the cycle increases, so during total REM
Between increase and improve sleep.Benzodiazepine hypnotic effect is good, but exists clearly disadvantageous.There is head on the 2nd day in patient
Confused, drowsiness, notice reduction, failure of memory, weak, incoordination etc. react, long-term taking be discontinued after easily occur knock-on and
Guard against medicine symptom.
Nervous headache is primarily referred to as tension headache, functional headache and angioneurotic headache, more by it is nervous,
Anger causes, and cardinal symptom is the vexed pain in head, constriction, sense of heaviness of continuation, and some patient's private prosecutions are that head has " lock ring "
Sense.Most patients are amphicrania, mostly two temporo sides, rear pillow part and overhead or full head.Headache property is dull pain, swollen
Bitterly, constriction, feeling of numbness and band sample lock ring sense.Vasoconstrictor, anodyne, antianxiety and sedative are used modern Western medicine more
Treatment.Although it is quick to take effect, drug dependence, side effect are all than larger.
Immunity is the defense mechanism of human body itself, is any foreign matter of human bioequivalence and the external intrusion of elimination, such as viral,
Bacterium etc., processing aging, damage, death, the own cells of denaturation and identification and processing vivo mutations cell and virus infection
The ability of cell.The body of hypoimmunity easily causes the infection such as bacterium, virus, fungi, therefore hypoimmunity is most direct
Performance be exactly liable to illness.Because often ill, aggravated the consumption of body, thus typically have a delicate constitution, it is malnutritive, smart
The performances such as refreshing dispirited, fatigue and weak, appetite reduction, sleep-disorder.Modern Western medicine is also without the effective treatment means of system.
The content of the invention
It is an object of the invention to overcome the deficiencies in the prior art, one kind is used to treat insomnia, nervous headache, immunity
Low Chinese medicine composition, the Chinese medicine composition prescription is simple, and active ingredient is clear and definite；Onset time is fast；Curative effect time is short；Take agent
Amount is small；Toxic side effect is small；And pharmacological dependence will not be produced.
The purpose of the present invention is achieved through the following technical solutions：A kind of Chinese medicine composition, mainly by following weight
The bulk drug of number is made：7 parts -9 parts of cow-bezoar, 15 parts -20 parts of calamus, 1 part -2 parts of the rhizome of Chinese monkshood, 3 parts -5 parts of Moschus, styrax 10
- 14 parts of part, 12 parts -15 parts of asafoetide, 1 part -2 parts of sulphur, 9 parts -12 parts of eclipta, 18 parts -25 parts of myrobalan.
Preferably, Chinese medicine composition is mainly made up of the bulk drug of following weight parts：8 parts -9 parts of cow-bezoar, 17 part -19 of calamus
Part, 1 part -1.5 parts of the rhizome of Chinese monkshood, 4 parts -5 parts of Moschus, 12 parts -14 parts of styrax, 13 parts -14 parts of asafoetide, 1 part -1.5 parts of sulphur, ink drought
10 parts -11 parts of lotus, 20 parts -23 parts of myrobalan.
Optimal, Chinese medicine composition is mainly made up of the bulk drug of following weight parts：8 parts of cow-bezoar, 18 parts of calamus, the rhizome of Chinese monkshood 1
Part, 4 parts of Moschus, 13 parts of styrax, 14 parts of asafoetide, 1 part of sulphur, 11 parts of eclipta, 22 parts of myrobalan.
It is preferred that, the Chinese medicine composition is prepared as any formulation of the prior art.
It is preferred that, the Chinese medicine composition is prepared as tablet.
It is preferred that, the Chinese medicine composition is prepared as capsule.
It is preferred that, the Chinese medicine composition is prepared as granule.
It is preferred that, the Chinese medicine composition is prepared as pill.
It is preferred that, the Chinese medicine composition is prepared as oral solutions.
It is preferred that, the Chinese medicine composition is prepared as powder.
It is preferred that, the Chinese medicine composition is prepared as sublimed preparation.
Function for each medicinal material in the present invention and effect below：
Cow-bezoar：It is bitter in taste, sweet, cool.Effect：Clear away heart-fire cool liver；Eliminate phlegm for resuscitation；It is clearing heat and detoxicating.Main pyreticosis coma；Apoplexy key
Close；Twitch；Acute infantile convulsion；Throat swells rotten；Aphthae；Ulcer serious case of furuncle.For pyreticosis coma, middle wind phlegm fan, frightened epilepsy is taken out
Jerk, epilepsy is gone mad, abscess of throat, aphthae, carbuncle swells furunculosis.
Calamus：Resuscitation with aromatics, goes turbid by phlegm.Effect：Calm, stomach invigorating, promotes digestive juice secretion, and analgesia releases intestinal tube and put down
Sliding muscle spasmus, diuresis.
The rhizome of Chinese monkshood：Nature and flavor are pungent, bitter, heat.Effect：Dispelling wind and eliminating dampness；It is warming channel and expelling cold；Swelling and pain relieving；.Main wind-cold-dampness arthralgia；Arthritis
Bitterly；Head wind headache；Apoplectic dyscinesia；Trusted subordinate's crymodynia；Cold hernia is had a pain；Traumatic injury；Blood stasis and swelling pain；Cloudy subcutaneous ulcer pyogenic infections；Narcotic analgesic.
Moschus：It is bitter in taste, warm, nontoxic.Effect：Enter the heart, spleen, Liver Channel, have and have one's ideas straightened out, ward off dirty, dredging collateral, scattered silt, cure mainly apoplexy,
Coma due to blocking of the respiratory system, frightened epilepsy, middle evil unhappiness, trusted subordinate sudden and violent pain, traumatic injury, swollen ulcer drug.
Styrax：Bitter in taste, temperature.Effect：Inducing resuscitation of having one's ideas straightened out；Slit phlegm is warded off dirty；The promoting flow of qi and blood circulation；Analgesic.Wind phlegm Jue in master；Frightened epilepsy
Stupor, postpartum anemic fainting；Trusted subordinate's pain；The wandering arthritis arthrodynia of extremeties.For apoplexy coma due to blocking of the respiratory system, bstruction of the circulation of vital energy is fainted cruelly, middle evil is gone into a coma, trusted subordinate's pain, production
Bruise, child convulsion afterwards.
Asafoetide：Nature and flavor are pungent, flat, nontoxic.Effect：Change disease disperse accumulations；Desinsection；Preventing malaria.Main abdominal mass lump in the abdomen；Malnutrition due to parasitic infestation；Dyspepsia；Chest and abdomen
Turgor；Crymodynia；Malaria；Dysentery.For meat stagnation, Yu Xue Disorder lumps in the abdomen, mass in abdomen, abdominal pain due to enterositosis.
Sulphur：Nature and flavor acid, heat.Effect：Supplementing fire and strengthening yang；Warm spleen defaecation；Desinsection is antipruritic.Main impotence；Seminal emission；Frequent micturition；Under band；
It is cold to breathe heavily；Trusted subordinate's crymodynia；Protracted dysentery and diarrhea；Constipation；Scabies；Stubborn dermatitis；The favus of the scalp；Pemphigus；Eczema of lower limb；The erosion of vulva；Cloudy subcutaneous ulcer；Malignant sore.
Eclipta：Nature and flavor are sweet, sour, cool in nature.Effect：Tonify the liver and kidney；Cooling blood and hemostasis.Main kidney deficiency and liver；Have a dizzy spell；Beard and hair
It is early white；Spit blood；Spitting of blood；Bleeding from five sense organs or subcutaneous tissue；Have blood in stool；Bloody flux；Collapse；Leakage；Traumatism and bleeding.Haematemesis is controlled, hemoptysis, bleeding from five sense organs or subcutaneous tissue, hematuria is had blood in stool, bloody flux,
Under knife wound bleeding, poliosis, diphtheria, stranguria with turbid discharge, band, private parts is wet to itch.
Myrobalan：It is bitter in taste, sour, puckery, mild-natured.Effect：There is the effect of clearing heat and promoting fluid, removing toxic substances, for deficiency of Yin diphtheria.
Beneficial effects of the present invention are：
(1) prescription is simple；
(2) active ingredient is clear and definite；
(3) onset time is fast；
(4) curative effect time is short；
(5) taking dose is small；
(6) toxic side effect is small；
(7) pharmacological dependence will not be produced；
Embodiment
The technical scheme in the embodiment of the present invention will be clearly and completely described below, it is clear that described implementation
Example only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, this area is common
The every other embodiment that technical staff is obtained under the premise of creative work is not made, belongs to the model that the present invention is protected
Enclose.
Embodiment 1：
A kind of Chinese medicine composition, is mainly made up of the bulk drug of following parts by weight：9 parts of cow-bezoar, 17 parts of calamus, the rhizome of Chinese monkshood
1.5 parts, 5 parts of Moschus, 12 parts of styrax, 13 parts of asafoetide, 1.5 parts of sulphur, 10 parts of eclipta, 23 parts of myrobalan；It is prepared as oral
Liquor.
Embodiment 2：
A kind of Chinese medicine composition, is mainly made up of the bulk drug of following parts by weight：8 parts of cow-bezoar, 18 parts of calamus, the rhizome of Chinese monkshood 1
Part, 4 parts of Moschus, 13 parts of styrax, 14 parts of asafoetide, 1 part of sulphur, 11 parts of eclipta, 22 parts of myrobalan；It is prepared as granule.
Chinese medicine composition in embodiment 2 is subjected to clinical observation：
(1) general information
The present inventor carried out clinical observation treatment, 15 to 80 years old ages to 500 out-patients so far in 2010.
(2) efficacy assessment standard
Cure：Symptom and sign is wholly absent；
Effectively：Symptom and sign mitigates earlier above；
It is invalid：Symptom and sign is preceding without improvement with treatment.
(3) therapeutic effect：
Clinical cure 490, accounts for 98%；Effective 10, invalid 0, total effective rate 100%.
It is used to treat insomnia, nervous headache, hypoimmunity Chinese medicine composition, the Chinese medicine group the invention discloses one kind
Compound prescription is simple, and active ingredient is clear and definite；Onset time is fast；Curative effect time is short；Taking dose is small；Toxic side effect is small；And will not
Produce pharmacological dependence.
Embodiment described above only expresses the embodiment of the present invention, and it describes more specific and detailed, but simultaneously
Therefore the limitation to the scope of the claims of the present invention can not be interpreted as.It should be pointed out that for one of ordinary skill in the art
For, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to the guarantor of the present invention
Protect scope.
Claims (11)
1. a kind of Chinese medicine composition, it is characterised in that be mainly made up of the bulk drug of following parts by weight：7 parts -9 parts of cow-bezoar, Chang
15 parts -20 parts of Pu, 1 part -2 parts of the rhizome of Chinese monkshood, 3 parts -5 parts of Moschus, 10 parts -14 parts of styrax, 12 parts -15 parts of asafoetide, 1 part -2 of sulphur
Part, 9 parts -12 parts of eclipta, 18 parts -25 parts of myrobalan.
2. a kind of Chinese medicine composition according to claim 1, it is characterised in that the main bulk drug by following parts by weight
It is made：8 parts -9 parts of cow-bezoar, 17 parts -19 parts of calamus, 1 part -1.5 parts of the rhizome of Chinese monkshood, 4 parts -5 parts of Moschus, 12 parts -14 parts of styrax, asafoetide
13 parts -14 parts, 1 part -1.5 parts of sulphur, 10 parts -11 parts of eclipta, 20 parts -23 parts of myrobalan.
3. a kind of Chinese medicine composition according to claim 1, it is characterised in that the main bulk drug by following parts by weight
It is made：8 parts of cow-bezoar, 18 parts of calamus, 1 part of the rhizome of Chinese monkshood, 4 parts of Moschus, 13 parts of styrax, 14 parts of asafoetide, 1 part of sulphur, 11 parts of eclipta,
22 parts of myrobalan.
4. a kind of Chinese medicine composition as described in claims 1 to 3 is any, it is characterised in that the Chinese medicine composition is prepared as existing
Any of technology formulation.
5. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as tablet.
6. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as capsule.
7. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as granule.
8. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as pill.
9. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as oral solutions.
10. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as powder.
11. a kind of Chinese medicine composition as claimed in claim 4, it is characterised in that the Chinese medicine composition is prepared as sublimed preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710420818.2A CN107213291A (en) | 2017-06-07 | 2017-06-07 | A kind of Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710420818.2A CN107213291A (en) | 2017-06-07 | 2017-06-07 | A kind of Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107213291A true CN107213291A (en) | 2017-09-29 |
Family
ID=59947574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710420818.2A Pending CN107213291A (en) | 2017-06-07 | 2017-06-07 | A kind of Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107213291A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1260201A (en) * | 1999-09-10 | 2000-07-19 | 张发平 | Chinese preparatory medicine and its preparation method |
| CN102755495A (en) * | 2011-04-25 | 2012-10-31 | 谭国菊 | Traditional Chinese medicinal plaster for treating trauma |
| EP2411030B1 (en) * | 2009-03-27 | 2014-01-29 | Council of Scientific & Industrial Research | Herbal extract of Casia tora leaves for use in the treatment of anxiety disorders |
| CN103611075A (en) * | 2013-09-13 | 2014-03-05 | 辽宁仙草堂药业股份有限公司 | Bezoar refreshing preparation and preparation method thereof |
-
2017
- 2017-06-07 CN CN201710420818.2A patent/CN107213291A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1260201A (en) * | 1999-09-10 | 2000-07-19 | 张发平 | Chinese preparatory medicine and its preparation method |
| EP2411030B1 (en) * | 2009-03-27 | 2014-01-29 | Council of Scientific & Industrial Research | Herbal extract of Casia tora leaves for use in the treatment of anxiety disorders |
| CN102755495A (en) * | 2011-04-25 | 2012-10-31 | 谭国菊 | Traditional Chinese medicinal plaster for treating trauma |
| CN103611075A (en) * | 2013-09-13 | 2014-03-05 | 辽宁仙草堂药业股份有限公司 | Bezoar refreshing preparation and preparation method thereof |
Non-Patent Citations (6)
| Title |
|---|
| 南京中医药大学: "《中药大辞典》", 31 March 2007, 上海科学技术出版社 * |
| 唐细兰: "《新药手册 兼述老药新用》", 30 November 2003, 羊城晚报出版社 * |
| 王文蜀: "《中国民族地区药用植物化学成分与药理作用》", 30 September 2013, 中央民族大学出版社 * |
| 纪申: "切勿滥用六神丸", 《开卷有益.求医问药》 * |
| 贾晓旭等: "开窍药研究概况", 《中国中医药信息杂志》 * |
| 郭建生: "《实用临床中药手册》", 31 August 2016, 湖南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103405596A (en) | Traditional Chinese medicine for treating sinusitis | |
| CN102772781B (en) | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof | |
| CN102772591B (en) | Hollow, ventilation and double-layer traditional Chinese medicine suppository for treating rhinitis and production method of traditional Chinese medicine suppository | |
| CN102670784B (en) | Chinese medicinal preparation for treating rhinitis and sinusitis | |
| CN104888122A (en) | Nursing traditional Chinese medicine for treating postpartum depression | |
| CN107158223A (en) | For clearing heat and detoxicating Chinese medicine preparation with anti-inflammatory and preparation method thereof | |
| CN102940780A (en) | Chinese medicinal composition for treating infantile enuresis | |
| CN104642678A (en) | Female beauty tranquilizing tea and preparation method thereof | |
| CN107213291A (en) | A kind of Chinese medicine composition | |
| CN101632756B (en) | Traditional Chinese medicine for treating malignant tumours and preparation method thereof | |
| CN108096344A (en) | A kind of Chinese medicine for treating rhinitis composition | |
| CN107158243A (en) | A kind of Chinese medicine preparation for treating chronic pharyngitis | |
| CN108785559B (en) | Medicine for treating respiratory tract infection and preparation method thereof | |
| CN109999098A (en) | It is a kind of for treating the traditional Chinese medicine for external application of cancer-related sleep disturbance | |
| CN108042650A (en) | A kind of beautifying face and moistering lotion medicinal liquor | |
| CN107184725A (en) | It is a kind of to treat Chinese medicine of diabetes and preparation method thereof | |
| CN105288095A (en) | Traditional Chinese medicinal composition for treating diabetes, and preparation method thereof | |
| CN106109768A (en) | A kind of Chinese medicine composition treating hemorrhoid | |
| CN115414462A (en) | A medicine for treating cancer by introducing odor and its preparation method | |
| CN104740403A (en) | Medicine for treating blood-insufficiency and yin-deficiency recurrent oral ulceration and preparation method thereof | |
| CN104857458B (en) | A kind of Traditional Chinese medicine for decreasing blood sugar combination preparation and preparation method thereof | |
| CN108210654A (en) | A kind of preparation method of the also red wine of grass | |
| CN113730542A (en) | Traditional Chinese medicine formula for treating allergic rhinitis | |
| CN110279820A (en) | A kind of Chinese medicine composition and preparation method thereof for treating insomnia | |
| CN107115504A (en) | A kind of pill medicine and preparation method for treating palpitation and uneasiness, insomnia and dreamful sleep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170929 |
|
| RJ01 | Rejection of invention patent application after publication |